For researchers tracking the broader market, understanding how cagrilintide and retatrutide compare with existing options like semaglutide vs tirzepatide provides important context
Key deciding factors for initiation of oral or subcutaneous semaglutide included: patient preference (fear of injection)
this may be due to the nature of the condition or via the limitation of therapeutic options available to these patients [7,8,9,10,11,12]
Methods of enzymatic analysis , 2nd edn
Prue Leith admits she took Mounjaro but it 'didn't do anything' The 86-year-old Great British Bake Off star took weight loss jabs after her husband lost three stone using Mounjaro Dame Prue Leith has revealed that she took the weight loss injection Mounjaro for a month but "did not lose a single pound", saying "I tried, but it didn't do anything"